Literature DB >> 8871143

Haemorheology in patients with branch retinal vein occlusion with and without risk factors.

A Remky1, O Arend, F Jung, H Kiesewetter, M Reim, S Wolf.   

Abstract

PURPOSE: The study was carried out to ascertain the role of blood viscosity in patients with branch retinal vein occlusion (BRVO) with and without risk factors.
METHODS: In 292 patients with acute BRVO (mean age 65 +/- 10 years) and 292 controls matched for gender, age, and cardiovascular risk factors, haematocrit, plasma viscosity, erythrocyte aggregation and erythrocyte rigidity were measured. A subgroup analysis in patients with and without risk factors was performed.
RESULTS: Haematocrit and plasma viscosity values were significantly higher in BRVO patients than in controls, but erythrocyte rigidity and erythrocyte aggregation did not differ. Subgroup analysis revealed no differences in haematocrit and plasma viscosity values between patients with and those without cardiovascular risk factors.
CONCLUSIONS: This study shows increased plasma viscosity and haematocrit values in patients with BRVO which are not associated with the presence of other cardiovascular risk factors. Thus, changes in blood fluidity appear to be important factors in the pathogenesis of BRVO.

Entities:  

Mesh:

Year:  1996        PMID: 8871143     DOI: 10.1007/bf02343041

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  Increased red blood cell aggregation in retinal vein occlusion.

Authors:  A Chabanel; A Glacet-Bernard; F Lelong; A Taccoen; G Coscas; M M Samama
Journal:  Br J Haematol       Date:  1990-05       Impact factor: 6.998

2.  [Randomized study of the effect of isovolemic hemodilution in retinal branch vein occlusion].

Authors:  L L Hansen; J Wiek; R Arntz
Journal:  Fortschr Ophthalmol       Date:  1988

3.  Anterior location of the crossing artery in branch retinal vein obstruction.

Authors:  J S Duker; G C Brown
Journal:  Arch Ophthalmol       Date:  1989-07

4.  Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions.

Authors:  A P Appiah; C L Trempe
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

5.  Abnormal blood viscosity and erythrocyte deformability in retinal vein occlusion.

Authors:  M Peduzzi; L Codeluppi; M Poggi; P Baraldi
Journal:  Am J Ophthalmol       Date:  1983-09       Impact factor: 5.258

6.  Viscosity and retinal vein thrombosis.

Authors:  C P Ring; T C Pearson; M D Sanders; G Wetherley-Mein
Journal:  Br J Ophthalmol       Date:  1976-06       Impact factor: 4.638

7.  Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.

Authors:  G E Trope; G D Lowe; B M McArdle; J T Douglas; C D Forbes; C M Prentice; W S Foulds
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

8.  Hemodilution therapy in central retinal vein occlusion. One-year results of a prospective randomized study.

Authors:  S Wolf; O Arend; B Bertram; A Remky; K Schulte; K J Wald; M Reim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-01       Impact factor: 3.117

9.  Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration.

Authors:  R L Letcher; S Chien; T G Pickering; J E Sealey; J H Laragh
Journal:  Am J Med       Date:  1981-06       Impact factor: 4.965

10.  [Effect of hemodilution on retinal hemodynamics in retinal branch vein occlusion].

Authors:  A Remky; S Wolf; M Hamid; B Bertram; K Schulte; O Arend; M Reim
Journal:  Ophthalmologe       Date:  1994-06       Impact factor: 1.059

View more
  4 in total

1.  Thrombus and branch retinal vein occlusion.

Authors:  A Remky; O Arend; B Bertram
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-12       Impact factor: 3.117

2.  Hypercoagulable states in patients with retinal venous occlusion.

Authors:  A M Abu El-Asrar; A G Abdel Gader; S Al-Amro; A K Al-Momen
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

3.  Hemodilution therapy using automated erythrocytapheresis in central retinal vein occlusion: results of a multicenter randomized controlled study.

Authors:  Agnès Glacet-Bernard; Marielle Atassi; Christine Fardeau; Jean-Paul Romanet; Matthieu Tonini; John Conrath; Philippe Denis; Martine Mauget-Faÿsse; Gabriel Coscas; Gisèle Soubrane; Eric Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-10-17       Impact factor: 3.117

Review 4.  [Retinal vein occlusion: Therapy of retinal vein occlusion].

Authors:  N Feltgen; A Pielen
Journal:  Ophthalmologe       Date:  2015-08       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.